Renaissance Technologies - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 94 filers reported holding TRINITY BIOTECH PLC in Q3 2014. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q3 2023$1,002
-23.3%
1,363,198
-0.7%
0.00%0.0%
Q2 2023$1,306
+0.9%
1,372,798
-0.3%
0.00%0.0%
Q1 2023$1,294
-6.2%
1,376,898
-1.2%
0.00%0.0%
Q4 2022$1,380
-99.9%
1,393,438
-3.1%
0.00%0.0%
Q3 2022$1,540,000
-16.4%
1,438,238
-4.3%
0.00%0.0%
Q2 2022$1,842,000
+18.3%
1,503,336
+2.4%
0.00%0.0%
Q1 2022$1,557,000
-30.6%
1,468,436
-6.4%
0.00%
-33.3%
Q4 2021$2,243,000
-40.6%
1,568,555
-10.2%
0.00%
-40.0%
Q3 2021$3,773,000
-30.6%
1,746,841
-5.6%
0.01%
-28.6%
Q2 2021$5,439,000
-21.6%
1,850,082
+0.3%
0.01%
-22.2%
Q1 2021$6,937,000
-4.5%
1,844,963
-3.2%
0.01%
+12.5%
Q4 2020$7,265,000
+114.6%
1,906,806
+13.8%
0.01%
+166.7%
Q3 2020$3,386,000
-1.6%
1,676,270
+6.2%
0.00%0.0%
Q2 2020$3,440,000
+257.6%
1,578,110
+80.5%
0.00%
+200.0%
Q1 2020$962,000
+35.5%
874,225
+27.2%
0.00%0.0%
Q4 2019$710,000
-13.7%
687,161
+1.0%
0.00%0.0%
Q3 2019$823,000
-27.2%
680,370
-0.7%
0.00%0.0%
Q2 2019$1,131,000
-35.3%
685,496
+11.7%
0.00%
-50.0%
Q1 2019$1,749,000
+28.2%
613,811
+3.0%
0.00%
+100.0%
Q4 2018$1,364,000
-42.1%
595,711
+1.1%
0.00%
-50.0%
Q3 2018$2,357,000
-53.9%
589,209
-41.6%
0.00%
-33.3%
Q2 2018$5,113,000
+115.4%
1,008,915
+118.8%
0.00%0.0%
Q1 2018$2,374,000
+16.7%
461,050
+15.6%
0.00%
+50.0%
Q4 2017$2,034,000
+30.2%
398,850
+43.2%
0.00%0.0%
Q3 2017$1,562,000
+12.7%
278,450
+20.6%
0.00%0.0%
Q2 2017$1,386,000
+41.3%
230,950
+40.3%
0.00%
+100.0%
Q1 2017$981,000
+4.3%
164,650
+21.1%
0.00%0.0%
Q4 2016$941,000
-70.0%
135,950
-42.7%
0.00%
-83.3%
Q3 2016$3,139,000
+70.3%
237,450
+46.1%
0.01%
+50.0%
Q2 2016$1,843,000
-18.6%
162,550
-16.3%
0.00%0.0%
Q1 2016$2,264,000
-4.7%
194,150
-3.9%
0.00%
-20.0%
Q4 2015$2,376,000
-5.3%
202,065
-7.8%
0.01%
-16.7%
Q3 2015$2,508,000
-48.3%
219,196
-18.3%
0.01%
-45.5%
Q2 2015$4,847,000
+2.0%
268,363
+8.7%
0.01%
+10.0%
Q1 2015$4,754,000
-16.4%
246,954
-24.0%
0.01%
-28.6%
Q4 2014$5,690,000
-27.6%
324,929
-24.5%
0.01%
-36.4%
Q3 2014$7,859,000
-24.3%
430,150
-4.6%
0.02%
-8.3%
Q2 2014$10,388,000
-4.8%
451,050
+0.2%
0.02%
-7.7%
Q1 2014$10,910,000
-10.6%
450,272
-7.2%
0.03%
-10.3%
Q4 2013$12,198,000
+10.3%
485,221
-4.5%
0.03%
+7.4%
Q3 2013$11,058,000
+62.0%
508,200
+25.5%
0.03%
+50.0%
Q2 2013$6,825,000405,0500.02%
Other shareholders
TRINITY BIOTECH PLC shareholders Q3 2014
NameSharesValueWeighting ↓
STONEHILL CAPITAL MANAGEMENT LLC 1,512,975$1,1121.76%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 1,732,395$1,2620.26%
Whitefort Capital Management, LP 409,517$301,0360.16%
Aristides Capital LLC 162,317$119,3190.05%
Redwood Wealth Management Group, LLC 16,650$12,2390.01%
WEALTHSOURCE PARTNERS, LLC 30,200$22,2000.00%
Renaissance Technologies 1,363,198$1,0020.00%
ACADIAN ASSET MANAGEMENT LLC 723,536$5260.00%
CGC Financial Services, LLC 1,500$1,1030.00%
CITIGROUP INC 4$30.00%
View complete list of TRINITY BIOTECH PLC shareholders